The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...

The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

UnitedHealth Group took quite the tumble on Thursday and Medicare Advantage troubles seem to largely be at fault. Its shares fell by over 22% after its first quarter earnings on Thursday.

The Department of Health and Human Services has long advocated vaccination as a key component of public health. Before Robert F. Kennedy, Jr. was confirmed as secretary of the nation’s top ...

The digital health funding market has been way up and way down over the past five years. As this roller coaster starts to settle down, one thing is clear to Randy Bolyga: that the industry is ...

A cancer drug from partners AstraZeneca and Daiichi Sankyo currently approved as a second-line or later treatment for metastatic breast cancer has interim clinical data showing it helped patients ...

Aeroflow Health, a health tech company, last week announced a new diabetes management program, which aims to improve adherence, outcomes and care coordination for health plan members. Asheville ...

Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the treatment of this inflammatory skin disorder.

Arundhati Parmar, Editor-in-Chief MedCity News interviews SCAN Health Plan CEO Sachin Jain at the Medicarians conference in Las Vegas, April 2. Straight talk is what everyone wants but rarely gets.